These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9133447)

  • 1. Alteration of p16 and p15 genes in common epithelial ovarian tumors.
    Fujita M; Enomoto T; Haba T; Nakashima R; Sasaki M; Yoshino K; Wada H; Buzard GS; Matsuzaki N; Wakasa K; Murata Y
    Int J Cancer; 1997 Apr; 74(2):148-55. PubMed ID: 9133447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of p16 and p15 genes in human uterine tumours.
    Nakashima R; Fujita M; Enomoto T; Haba T; Yoshino K; Wada H; Kurachi H; Sasaki M; Wakasa K; Inoue M; Buzard G; Murata Y
    Br J Cancer; 1999 May; 80(3-4):458-67. PubMed ID: 10408854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of p16/CDKN2 and p15/MTS2 genes in different histological types and clinical stages of primary ovarian tumors.
    Ichikawa Y; Yoshida S; Koyama Y; Hirai M; Ishikawa T; Nishida M; Tsunoda H; Kubo T; Miwa M; Uchida K
    Int J Cancer; 1996 Dec; 69(6):466-70. PubMed ID: 8980248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of p16INK4A and p15INK4B genes in gastric carcinomas.
    Lee YY; Kang SH; Seo JY; Jung CW; Lee KU; Choe KJ; Kim BK; Kim NK; Koeffler HP; Bang YJ
    Cancer; 1997 Nov; 80(10):1889-96. PubMed ID: 9366289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of the p53 tumor suppressor gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial tumors of the human ovary.
    Fujita M; Enomoto T; Inoue M; Tanizawa O; Ozaki M; Rice JM; Nomura T
    Jpn J Cancer Res; 1994 Dec; 85(12):1247-56. PubMed ID: 7852189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infrequent mutations and no methylation of CDKN2A (P16/MTS1) and CDKN2B (p15/MTS2) in hepatocellular carcinoma in Taiwan.
    Lin YW; Chen CH; Huang GT; Lee PH; Wang JT; Chen DS; Lu FJ; Sheu JC
    Eur J Cancer; 1998 Oct; 34(11):1789-95. PubMed ID: 9893670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
    Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
    Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
    J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion and differential expression of p16INK4a in mouse lung tumors.
    Belinsky SA; Swafford DS; Middleton SK; Kennedy CH; Tesfaigzi J
    Carcinogenesis; 1997 Jan; 18(1):115-20. PubMed ID: 9054597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.
    Sonoda Y; Yoshimoto T; Sekiya T
    Oncogene; 1995 Nov; 11(10):2145-9. PubMed ID: 7478535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p16/MTS1 inactivation in ovarian carcinomas: high frequency of reduced protein expression associated with hyper-methylation or mutation in endometrioid and mucinous tumors.
    Milde-Langosch K; Ocon E; Becker G; Löning T
    Int J Cancer; 1998 Feb; 79(1):61-5. PubMed ID: 9495360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple types of aberrations in the p16 (INK4a) and the p15(INK4b) genes in 30 esophageal squamous-cell-carcinoma cell lines.
    Tanaka H; Shimada Y; Imamura M; Shibagaki I; Ishizaki K
    Int J Cancer; 1997 Feb; 70(4):437-42. PubMed ID: 9033652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homozygous deletions but no sequence mutations in coding regions of p15 or p16 in human primary bladder tumors.
    Packenham JP; Taylor JA; Anna CH; White CM; Devereux TR
    Mol Carcinog; 1995 Nov; 14(3):147-51. PubMed ID: 7576106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of deletions but frequent loss of expression of p16INK4 in human ovarian tumours.
    Marchini S; Codegoni AM; Bonazzi C; Chiari S; Broggini M
    Br J Cancer; 1997; 76(2):146-9. PubMed ID: 9231912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
    Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
    Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R; Shiohara M; Koeffler HP; Fagin JA
    Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
    Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR
    Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p16(CDKN2) gene polymorphism: association with histologic subtypes of epithelial ovarian cancer in China.
    Yan L; Na W; Shan K; Xiao-Wei M; Wei G; Shu-Cheng C
    Int J Gynecol Cancer; 2008; 18(1):30-5. PubMed ID: 17466040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent codeletion of p16/MTS1 and p15/MTS2 and genetic alterations in p16/MTS1 in pancreatic tumors.
    Naumann M; Savitskaia N; Eilert C; Schramm A; Kalthoff H; Schmiegel W
    Gastroenterology; 1996 Apr; 110(4):1215-24. PubMed ID: 8613012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities of tumor suppressor genes P16 and P15 in primary maxillofacial squamous cell carcinomas.
    Zhao Y; Zhang S; Fu B; Xiao C
    Cancer Genet Cytogenet; 1999 Jul; 112(1):26-33. PubMed ID: 10432931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.